DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML
Clinical trial NCT01898663 · UNKNOWN
Trial details
- NCT number
- NCT01898663
- Sponsor
- Affiliated Hospital to Academy of Military Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2024-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.